Ocular Therapeutix, Inc. (OCUL) NASDAQ

8.10

+0.28(+3.58%)

Updated at February 05 03:25PM

Currency In USD

Valuation

Market Cap356.03M
Enterprise Value243.61M
P/E Ratio-7.76
PEG Ratio0.41
Price/Sales Ratio20.75
Price/Book Ratio3.84
Enterprise/Revenue15.01
Enterprise/EBITDA-5.91

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-2.84
Operating Margin-2.3

Management Effectiveness

Return On Assets-0.36
Return On Equity-0.57

Income Statement

Revenue58.44M
Revenue/Share0.37
Gross Profit53.16M
EBITDA-66.42M
Net Income-80.74M
Diluted EPS-1.02

Balance Sheet

Total Cash427.22M
Total Cash/Share2.56
Total Debt75.12M
Total Debt/Equity0.21
Current Ratio13.01
Book Value Per Share2.11

Price History

52-Week Change63.64
52-Week High11.78
52-Week Low4.06
Moving Average 50 Days8.66
Moving Average 200 Days8.07

Statistics

Average Volume908,005
Shares Outstanding157.22M
% Held by Institutions83.82

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A